Atorvastatin promotes AMPK signaling to protect against high fat diet-induced non-alcoholic fatty liver in golden hamsters

Non-alcoholic fatty liver disease (NAFLD) is characterized by diffuse fatty acid degeneration and excess fat accumulation in the liver. Notably, the currently available medications used to treat NAFLD remain limited. The aim of the present study was to investigate the protective role of atorvastatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bin, Zhang, Chenyang, Zhang, Xuelian, Li, Nannan, Dong, Zhengqi, Sun, Guibo, Sun, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027324/
https://www.ncbi.nlm.nih.gov/pubmed/32104276
http://dx.doi.org/10.3892/etm.2020.8465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027324/
https://www.ncbi.nlm.nih.gov/pubmed/32104276
http://dx.doi.org/10.3892/etm.2020.8465

Ejemplares similares